Jincheng Pharmaceutical (300233.SZ) released its first three quarters results, with net profit attributable to shareholders of RMB 145 million, up 357.73% year on year.

Zhitong Finance APP News, Jincheng Pharmaceutical (300233.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 2.029 billion yuan, a year-on-year increase of 5.05%. Net profit attributable to shareholders of the listed company was 145 million yuan, a year-on-year increase of 357.73%. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 68.0979 million yuan, a year-on-year increase of 210.81%.